Merck (MRK) Other Non-Current Liabilities (2009 - 2026)

Merck has disclosed Other Non-Current Liabilities across 17 years of filings, most recently posting $7.6 billion for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 14.83% year-over-year to $7.6 billion; the TTM figure through Mar 2026 stood at $7.6 billion (up 14.83% YoY), while the FY2025 annual figure was $7.7 billion, up 18.92% from the prior year.
• Other Non-Current Liabilities fell to $7.6 billion in Q1 2026, from $7.7 billion in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for MRK reached as high as $9.7 billion in Q1 2022 and fell as low as $208.0 million in Q3 2024.
• The 5-year median for Other Non-Current Liabilities is $6.5 billion (2024), against an average of $4.2 billion.
• Annual changes were most pronounced in 2024 — Other Non-Current Liabilities slumped 97.17% — and 2025, when it jumped 3583.17%.
• A 5-year view of Other Non-Current Liabilities shows it stood at $8.3 billion in 2022, then slumped by 95.75% to $354.0 million in 2023, then surged by 1726.27% to $6.5 billion in 2024, then increased by 18.92% to $7.7 billion in 2025, then retreated by 0.6% to $7.6 billion in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $7.6 billion, $7.7 billion, and $7.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.